Singular Health Group Ltd (ASX:SHG)
0.3000
+0.0100 (3.45%)
May 2, 2025, 4:10 PM AEST
Singular Health Group Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Operating Revenue | 0.88 | 0.93 | 0.44 | 0.42 | 0.46 | 0.13 |
Other Revenue | - | - | - | 0 | 0 | - |
Revenue | 0.88 | 0.93 | 0.44 | 0.42 | 0.46 | 0.13 |
Revenue Growth (YoY) | 84.40% | 111.17% | 5.79% | -8.79% | 260.66% | - |
Cost of Revenue | 0.56 | 0.42 | 0.59 | 0.6 | 0.19 | 0 |
Gross Profit | 0.32 | 0.52 | -0.15 | -0.18 | 0.27 | 0.12 |
Selling, General & Admin | 2.49 | 2.19 | 2.67 | 2.79 | 2.45 | 0.89 |
Other Operating Expenses | 0.52 | 0.03 | 0.01 | 0.03 | -0.04 | -0.02 |
Operating Expenses | 4.18 | 3.61 | 4.22 | 5.74 | 3.26 | 0.91 |
Operating Income | -3.86 | -3.09 | -4.37 | -5.92 | -2.99 | -0.78 |
Interest Expense | -0.04 | -0.1 | -0.43 | -0.01 | -1.46 | -0.07 |
Interest & Investment Income | 0.05 | 0.31 | 0 | 0.01 | 0 | 0 |
Earnings From Equity Investments | - | - | -0.01 | -0.06 | -0 | - |
EBT Excluding Unusual Items | -3.85 | -2.87 | -4.81 | -5.99 | -4.46 | -0.85 |
Gain (Loss) on Sale of Investments | -0 | -0 | -0.16 | - | - | - |
Other Unusual Items | - | - | - | - | - | -0 |
Pretax Income | -3.86 | -2.88 | -4.97 | -5.99 | -4.46 | -0.85 |
Earnings From Continuing Operations | -3.86 | -2.88 | -4.97 | -5.99 | -4.46 | -0.85 |
Earnings From Discontinued Operations | -1.85 | -2.05 | -0.42 | - | - | - |
Net Income | -5.7 | -4.92 | -5.39 | -5.99 | -4.46 | -0.85 |
Net Income to Common | -5.7 | -4.92 | -5.39 | -5.99 | -4.46 | -0.85 |
Shares Outstanding (Basic) | 165 | 160 | 110 | 103 | 74 | 15 |
Shares Outstanding (Diluted) | 165 | 160 | 110 | 103 | 74 | 15 |
Shares Change (YoY) | 39.61% | 45.63% | 6.98% | 38.82% | 396.41% | - |
EPS (Basic) | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 | -0.06 |
EPS (Diluted) | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 | -0.06 |
Free Cash Flow | -3.23 | -2.51 | -2.43 | -2.92 | -1.96 | -0.66 |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
Gross Margin | 36.33% | 55.28% | -32.87% | -43.02% | 58.60% | 96.79% |
Operating Margin | -439.57% | -330.80% | -987.82% | -1415.80% | -652.20% | -615.77% |
Profit Margin | -649.73% | -527.23% | -1218.59% | -1431.58% | -972.05% | -668.03% |
Free Cash Flow Margin | -367.48% | -269.13% | -548.25% | -697.75% | -427.04% | -517.52% |
EBITDA | -3.43 | -2.62 | -4.05 | -5.72 | -2.9 | -0.74 |
EBITDA Margin | - | -280.41% | - | - | - | - |
D&A For EBITDA | 0.42 | 0.47 | 0.32 | 0.2 | 0.09 | 0.04 |
EBIT | -3.86 | -3.09 | -4.37 | -5.92 | -2.99 | -0.78 |
Advertising Expenses | - | - | - | - | 0.05 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.